Current and Emerging Technologies to Characterize the Higher-Order Structure of Monoclonal Antibodies

Published

October 15, 2015

Author(s)

John Marino, Robert G. Brinson, Jane E. Ladner, David Travis Gallagher, Luke Arbogast, Richard Huang, Jeffrey W. Hudgens, Elyssia S. Gallagher

Abstract

In contrast to small molecule therapeutics whose conformations can be absolutely defined by constitution and stereochemistry, biopharmaceuticals are distinguished by the requirement for folding into higher order structures (secondary, tertiary, and quaternary) for therapeutic function. While proper folding of a protein biologic is critical for drug efficacy, misfolding may impact drug safety by eliciting unwanted immune or other off-target patient responses. In this chapter, we review current and emerging technologies for high-resolution characterization of the structure and dynamics of monoclonal antibodies (mAbs) with a focus on techniques that can provide data at and or near atomic resolution, such as X-ray crystallography, nuclear magnetic resonance (NMR) and HDX-mass spectrometry. Application of these techniques is illustrated using the NIST mAb.

Citation

Current, State of the Art, and Emerging Technolgies for the Analysis of Monoclonal Antibodies

Volume

1202

Publisher Info

American Chemical Society, Washington, DC

Pub Type

Books

Download Paper

DOI Link

Keywords

mAb, NMR, X-ray Crystallography, HDX-MS, higher order structure

Citation

Marino, J. , Brinson, R. , Ladner, J. , Gallagher, D. , Arbogast, L. , Huang, R. , Hudgens, J. and Gallagher, E. (2015), Current and Emerging Technologies to Characterize the Higher-Order Structure of Monoclonal Antibodies, American Chemical Society, Washington, DC, [online], https://doi.org/10.1021/bk-2015-1202.ch002 (Accessed April 23, 2024)